Gland Pharma IPO Subscribed 9% So Far On Day 2
(Photographer: Andrey Rudakov/Bloomberg)

Gland Pharma IPO Subscribed 9% So Far On Day 2

Response to Gland Pharma Ltd.'s initial public offering remained muted on the second day of bidding.The issue was subscribed 9% as of 2:20 pm on Nov. 10, led by retail investors who bid for 11% of ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.